drugset / Trial / NCT00583713
An Open Label Study to Assess the Effect of BLI800 on Safety and Clinical Chemistry Parameters
Non-randomizedParallel-groupOpen-labelTreatment
Summary
To evaluate and compare the effects on safety measures and clinical chemistry after BLI800 in two groups of patients and one group of healthy controls. The patient groups will be those with mild or moderate hepatic impairment or moderate renal disease.
Timeline
- Start
- 2007-08
- Primary completion
- 2008-04
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BLI800 | Unknown | — | Oral |
Indications
No indication recorded.